Carl Borrebaeck
OTHER
INVESTOR TYPE
1
INVESTMENTS
1
EXITS
Description
Dr. Carl Borrebaeck is a Co-Founder and serves as Chief Executive Officer & Chairman at PainDrainer. Prof. Carl Borrebaeck is a serial company builder and serves presently as chairman of Immunovia and SenzaGen. He is a Co-Founder & serves as Chief Executive Officer at PainDrainer. Dr. Borrebaeck is the previous Vice-President of Lund University, and serves presently as Director of CREATE Health Cancer Center at Lund University Bioscience. He also serves as a board member at Alligator Bioscience. His main research interests are cancer proteomics for early detection and immuno-oncology. He received the AKZO Nobel Science Award 2009, for his contributions to cancer proteomics and antibody-based therapy, the Research!Sweden Award 2012 for his medical research of value for patients and health organizations, and the Royal Academy of Engineering Sciences Gold Medal 2012 for outstanding contributions to biomedical science.
Primary Investor Type
Angel (individual)
Primary Office
- Medicon Village Building 601
- Scheelevägen 2
- 223 63 Lund
- Sweden
Carl Borrebaeck Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 000000000 00000000 | 29-May-2007 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0000000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Carl Borrebaeck’s full profile, request a free trial.
Carl Borrebaeck Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 00000000 | 23-Nov-2016 | 000 | 000.00 | Completed |
|